USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Samplix APS

USPTO PatentsView assignee record - 10 granted patents across 4 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Samplix ranks #27,300 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 4 technology areas.

#27,300
of 49,997 US assignees by volume
Top 48%
by Innovation Score (35.8/100)
17.4
avg claims per patent
+800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27300 · Foreign Corporation #27,300 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #27,300/49,997
  • PHOTO-FINISH Sabre Intellectual…
  • CPC-NARROW C12Q · 4 areas
  • INNOV-THIN 35.8/100
  • CLAIMS-RICH 17.4 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +800% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sabre Intellectual Property Holdings LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Samplix

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Samplix's Innovation Score is 35.8/100 (top 48% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Samplix's grants concentrate

Samplix APS is a focused PatentsView assignee: 4 CPC subclasses with 60% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2023 (3 grants) versus a trough of 1 in 2019. By volume, Samplix sits between Sabre Intellectual Property Holdings LLC and Sasol Technology (PTY.) Limited.

Samplix's three-year grant acceleration

Samplix APS shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Samplix's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Samplix holds 10 patents at rank #27,290, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Samplix

By rank, the assignees closest to #27,290 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Samplix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Samplix, neither rank-band nor same-CPC leaders (those blocks stay above).

Samplix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 48% higher than 52% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 201920202021202220232024 2
USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Samplix APS patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 1 10.0%
2020 2 20.0%
2021 1 10.0%
2022 1 10.0%
2023 3 30.0%
2024 2 20.0%

Where it ranks

Overall rank by patents

#27,300

of 49,997 tracked assignees

Innovation Score

35.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Samplix APS's patent record in context - here's where to go next.

  • Samplix APS's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 60% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #27,300 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Samplix APS against Sabre Intellectual Property Holdings LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 35.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.